IAVI and its partners are advancing a diverse porfolio of select preventive HIV vaccine candidates.
IAVI details its organizational strategic vision for the period 2011-2015 made.
Engage with IAVI on your social media networks.
China is poised to assume greater leadership in one of the most important intersections of public health and innovation: the development of a vaccine to prevent HIV infection. This study examines the policy environment for AIDS vaccine R&D in China and identifies policies that could bolster the country’s efforts in that field of research.
International AIDS Vaccine Initiative. All rights reserved. International AIDS Vaccine Initiative, IAVI and the IAVI logo are trademarks of the International AIDS Vaccine Initiative, Inc.